tecastemizole has been researched along with granisetron in 3 studies
| Studies (tecastemizole) | Trials (tecastemizole) | Recent Studies (post-2010) (tecastemizole) | Studies (granisetron) | Trials (granisetron) | Recent Studies (post-2010) (granisetron) |
|---|---|---|---|---|---|
| 18 | 0 | 3 | 59 | 0 | 16 |
| Protein | Taxonomy | tecastemizole (IC50) | granisetron (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 4.3 | |
| D | Rattus norvegicus (Norway rat) | 3.8019 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.8019 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 3.8019 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 3.8019 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 3.8019 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 1.76 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.7702 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 5 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 1.76 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalli, A; De Ponti, F; Poluzzi, E; Recanatini, M | 1 |
| Li, J; Rajamani, R; Reynolds, CH; Tounge, BA | 1 |
| Caron, G; Ermondi, G; Visentin, S | 1 |
3 other study(ies) available for tecastemizole and granisetron
| Article | Year |
|---|---|
Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers.
Topics: Anti-Arrhythmia Agents; Cation Transport Proteins; Cluster Analysis; Databases, Factual; Ether-A-Go-Go Potassium Channels; Long QT Syndrome; Models, Molecular; Molecular Conformation; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2002 |
A two-state homology model of the hERG K+ channel: application to ligand binding.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Ligands; Models, Biological; Models, Molecular; Potassium Channels, Voltage-Gated; Protein Binding; Protein Conformation | 2005 |
GRIND-based 3D-QSAR and CoMFA to investigate topics dominated by hydrophobic interactions: the case of hERG K+ channel blockers.
Topics: Ether-A-Go-Go Potassium Channels; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Potassium Channel Blockers; Quantitative Structure-Activity Relationship | 2009 |